Ageing Research Reviews · Nov 16, 2026
Cancer- and treatment-related accelerated biological ageing and cognitive frailty in older adults: Mechanisms and clinical implications
By Su L, Liu Q, Qiu L et al.
Cancer and its treatments may induce biological changes overlapping with the hallmarks of ageing, potentially contributing to cognitive and physical vulnerability in older adults. This narrative review examines the potential links between cancer- and treatment-associated ageing-related changes and cognitive frailty from a geroscience perspective. Cellular senescence, inflammatory signalling, mitochondrial dysfunction, and metabolic dysregulation may contribute to neural and muscular vulnerability, while physiological reserve and resilience may influence individual trajectories. However, current evidence derives largely from indirect clinical observations, non-cancer populations, and preclinical studies. Direct longitudinal evidence linking accelerated systemic biological ageing to cognitive frailty in older adults with cancer remains limited. Geriatric assessment provides an established framework for identifying multidimensional vulnerability, whereas biological ageing biomarkers and digital phenotyping require further validation for risk stratification. Integrating these measures may inform future precision geriatric oncology approaches, although their incremental clinical value remains uncertain. Exercise, nutritional support, and symptom management may improve selected functional outcomes, but their effects on biological ageing and cognitive frailty prevention remain unproven. Prospective longitudinal studies incorporating pretreatment assessments, repeated biological and functional measurements, and appropriate comparison groups are needed to clarify causal relationships and guide personalised interventions.